Scientific Reports (Mar 2022)

PET in vivo generators 134Ce and 140Nd on an internalizing monoclonal antibody probe

  • G. W. Severin,
  • J. Fonslet,
  • L. K. Kristensen,
  • C. H. Nielsen,
  • A. I. Jensen,
  • A. Kjær,
  • A. P. Mazar,
  • K. Johnston,
  • U. Köster

DOI
https://doi.org/10.1038/s41598-022-07147-x
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 7

Abstract

Read online

Abstract The in vivo-generator radionuclides 140Nd (t1/2 = 3.4 d) and 134Ce (t1/2 = 3.2 d) were used to trace a urokinase-type plasminogen activator (uPA)-targeting mouse monoclonal antibody, ATN-291, in U87 MG xenograft tumor-bearing mice. ATN-291 is known to internalize on the uPA/uPA-receptor pair, making it an appropriate targeting vector for investigating the fate of in vivo generator daughters on internalizing probes. Ante-mortem and post-mortem PET imaging at 120 h post-injection gave no indication of redistribution of the positron emitting daughter nuclides 134La and 140Pr from tumor tissue (p > 0.5). The lack of redistribution indicates that the parent radionuclides 134Ce and 140Nd could be considered as long-lived PET-diagnostic matches to therapeutic radionuclides like 177Lu, 161Tb and 225Ac when internalizing bioconjugates are employed.